Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange Detected- Revision updated from v3.6.3 to v3.6.4, indicating a minor site update. The change does not alter study content or user-facing functionality.SummaryDifference0.1%

- Check21 days agoChange DetectedStudy timeline details were updated to show actual dates and enrollment, including a Primary Completion date of 2026-12-30 and a Study Completion date of 2027-12-30. Enrollment is now listed as 14, and the status labels indicate actual milestones rather than estimates.SummaryDifference0.6%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now reflects a new Revision: v3.6.3, replacing the previous v3.6.2 revision. This is a metadata update indicating a released update to the page content without altering substantive information.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer release of the page template or metadata. This update does not alter the visible content or study details.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now shows recruitment status indicating no participants are being sought, and adds or updates help and navigation sections such as How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment header. The footer revision label changes from Revision: v3.5.5 to Revision: v3.6.0.SummaryDifference0.4%

- Check64 days agoChange DetectedThe page revision indicator was updated from v3.5.4 to v3.5.5, signaling a recent update to the study record on ClinicalTrials.gov. This represents a small, system-level refresh to the page rather than a change to the study data.SummaryDifference0.1%

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.